Litigation Details for Athenex Pharma Solutions, LLC v. Par Pharmaceutical, Inc. (W.D.N.Y. 2018)
✉ Email this page to a colleague
Athenex Pharma Solutions, LLC v. Par Pharmaceutical, Inc. (W.D.N.Y. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-08-13 |
Court | District Court, W.D. New York | Date Terminated | 2019-07-10 |
Cause | 28:2201 Declaratory Judgement | Assigned To | Geoffrey Crawford |
Jury Demand | Plaintiff | Referred To | |
Patents | 9,375,478; 9,687,526; 9,744,209; 9,744,239; 9,750,785; 9,937,223 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Athenex Pharma Solutions, LLC v. Par Pharmaceutical, Inc.
Details for Athenex Pharma Solutions, LLC v. Par Pharmaceutical, Inc. (W.D.N.Y. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-08-13 | 1 | Complaint | invalidity of U.S. Patent Nos. 9,375,478 (“the ’478 patent”); 9,687,526 (“the ’526 patent”); 9,744,209 (“…s five unexpired patents listed in FDA’s Orange Book, see U.S. Patent Nos. 9,375,478; 9,687,526; 9,744,209… six patents-in-suit, namely the ’478 patent, the ’526 patent, the ’209 patent, the ’239 patent, and …(“the ’209 patent”); 9,744,239 (“the ’239 patent”); 9,750,785 (“the ’785 patent”); and 9,937,223 (“the…the ’223 Patent”) (collectively, “the patents-in-suit”). Case 1:18-cv-00896-GWC Document 1 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |